YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
3.240
-0.460 (-12.43%)
At close: Sep 17, 2026, 4:00 PM EDT
3.190
-0.050 (-1.54%)
After-hours: Sep 17, 2026, 7:30 PM EDT
YD Bio Market Cap
YD Bio has a market cap or net worth of $227.84 million as of September 17, 2026. Its market cap has decreased by -81.00% in one year.
Market Cap
227.84M
Enterprise Value
225.18M
1-Year Change
-81.00%
Ranking
Category
Stock Price
$3.24
ChartMarket Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $227.84M, an increase of 53.57%. That is a compound annual growth rate of 7.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 227.84M | -73.42% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 280.14M |
| Lyell Immunopharma | 277.64M |
| Bicycle Therapeutics | 272.27M |
| Lineage Cell Therapeutics | 270.61M |
| MacroGenics | 267.54M |
| Camp4 Therapeutics | 266.70M |
| ALX Oncology Holdings | 266.18M |
| AC Immune | 264.48M |